EDMONTON, AB, Sept. 13, 2023 /CNW/ - Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company") wishes to provide an update to its June 2 and June 6, 2023 news releases announcing the entry into of a non-binding agreement in principle (the "Agreement in Principle") with OQP Bio Inc. ("OQP Bio") for the potential monetization of bonds held by Quest in OQP Bio.
Read more at newswire.caProvided Content: Content provided by Newswire.ca. The Globe and Mail was not involved, and material was not reviewed prior to publication.